scispace - formally typeset
Open AccessJournal ArticleDOI

The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism

Raphael Kopan, +1 more
- 17 Apr 2009 - 
- Vol. 137, Iss: 2, pp 216-233
TLDR
This Review highlights recent studies in Notch signaling that reveal new molecular details about the regulation of ligand-mediated receptor activation, receptor proteolysis, and target selection.
About
This article is published in Cell.The article was published on 2009-04-17 and is currently open access. It has received 3120 citations till now. The article focuses on the topics: Notch signaling pathway & Notch 1.

read more

Citations
More filters
Journal ArticleDOI

FOXP1 Promotes Embryonic Neural Stem Cell Differentiation by Repressing Jagged1 Expression

TL;DR: A role for FOXP1 is supported in regulating embryonic NSC differentiation by modulating Notch signaling by repressing the expression of Notch pathway genes including the Notch-ligand Jagged1, resulting in inhibition of NotCh signaling.
Patent

Binding-triggered transcriptional switches and methods of use thereof

TL;DR: The present disclosure as mentioned in this paper provides binding-triggered transcriptional switch polypeptides, nucleic acids comprising nucleotide sequences encoding the binding triggered transcriptional switches, and host cells genetically modified with the nucleic acid.
Journal ArticleDOI

Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest

TL;DR: A molecular mechanism whereby information provided by Hes/Hey downstream of Notch as well as MRF activities are integrated at the level of the p57kip2 enhancer to regulate the decision between progenitor cell maintenance and muscle differentiation is proposed.
Journal ArticleDOI

Histone lysine demethylases in breast cancer

TL;DR: It is determined that the expression of KDMs correlates with BC prognosis, and altering the interactions between KDMs and Polycomb Group genes (PcG) may provide novel avenues for therapy that specifically targets these genes in BC.
Journal ArticleDOI

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

TL;DR: Tarextumab was generally well-tolerated at doses <2.5 mg weekly and 7.5-mg/kg on the every other and every three week schedules, and inhibition of Notch pathway signaling was demonstrated at these doses.
References
More filters
Journal ArticleDOI

Notch signalling: a simple pathway becomes complex

TL;DR: Although the intracellular transduction of the Notch signal is remarkably simple, with no secondary messengers, this pathway functions in an enormous diversity of developmental processes and its dysfunction is implicated in many cancers.
Journal ArticleDOI

Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain.

TL;DR: It is shown that signalling by a constitutively active membrane-bound Notch-1 protein requires the proteolytic release of the Notch intracellular domain (NICD), which interacts preferentially with CSL.
Journal ArticleDOI

Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells.

TL;DR: This work shows a rapid, massive conversion of proliferative crypt cells into post-mitotic goblet cells after conditional removal of the common Notch pathway transcription factor CSL/RBP-J and indicates that γ-secretase inhibitors, developed for Alzheimer's disease, might be of therapeutic benefit in colorectal neoplastic disease.
Related Papers (5)